Skip to main content
. 2022 May 25;27(11):3403. doi: 10.3390/molecules27113403

Figure 3.

Figure 3

NGR1 upregulated the expression of osteogenic markers ALP, COL1A1, and OCN, as well as pro-angiogenic growth factor VEGF in hASCs. (A) ALP and (B) COL1A1 expression in hASCs treated with vehicle (control) or 0.05 µg/mL NGR1 for 1, 4 and 7 days, n = 3. Data were analyzed with two-way ANOVA with Tukey’s multiple comparison test. (C) OCN and (D) VEGF expression in hASCs treated with vehicle (control) or 0.05 µg/mL NGR1 for 7 days, n = 3. Data were analyzed with unpaired t-test.* p < 0.05, ** p < 0.01, *** p < 0.001 relative to controls.